FI103668B1 - Förfarande för framställning av farmakologiskt aktiva pyrrolo[3,2-e]indol-4(5H)-onidimerer - Google Patents

Förfarande för framställning av farmakologiskt aktiva pyrrolo[3,2-e]indol-4(5H)-onidimerer

Info

Publication number
FI103668B1
FI103668B1 FI911193A FI911193A FI103668B1 FI 103668 B1 FI103668 B1 FI 103668B1 FI 911193 A FI911193 A FI 911193A FI 911193 A FI911193 A FI 911193A FI 103668 B1 FI103668 B1 FI 103668B1
Authority
FI
Finland
Prior art keywords
pct
unidimers
indole
preparation
pharmacologically active
Prior art date
Application number
FI911193A
Other languages
English (en)
Finnish (fi)
Other versions
FI911193A0 (fi
FI103668B (sv
Inventor
Robert C Kelly
Paul A Aristoff
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI911193A0 publication Critical patent/FI911193A0/fi
Application granted granted Critical
Publication of FI103668B publication Critical patent/FI103668B/sv
Publication of FI103668B1 publication Critical patent/FI103668B1/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Error Detection And Correction (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Amplifiers (AREA)
  • Solid State Image Pick-Up Elements (AREA)
  • Artificial Filaments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Television Receiver Circuits (AREA)
  • Stereophonic System (AREA)
  • Television Systems (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI911193A 1988-09-12 1991-03-11 Förfarande för framställning av farmakologiskt aktiva pyrrolo[3,2-e]indol-4(5H)-onidimerer FI103668B1 (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12
US24335088 1988-09-12
US8903329 1989-08-07
PCT/US1989/003329 WO1990002746A1 (en) 1988-09-12 1989-08-07 Novel cc-1065 analogs having two cpi subunits

Publications (3)

Publication Number Publication Date
FI911193A0 FI911193A0 (fi) 1991-03-11
FI103668B FI103668B (sv) 1999-08-13
FI103668B1 true FI103668B1 (sv) 1999-08-13

Family

ID=22918400

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911193A FI103668B1 (sv) 1988-09-12 1991-03-11 Förfarande för framställning av farmakologiskt aktiva pyrrolo[3,2-e]indol-4(5H)-onidimerer

Country Status (14)

Country Link
US (1) US5541339A (sv)
JP (1) JP3380237B2 (sv)
KR (1) KR0137959B1 (sv)
AT (1) ATE198335T1 (sv)
AU (1) AU632288B2 (sv)
CA (1) CA1340215C (sv)
DE (1) DE68929275T2 (sv)
DK (1) DK175458B1 (sv)
FI (1) FI103668B1 (sv)
GR (1) GR3035589T3 (sv)
LV (1) LV12806B (sv)
NO (1) NO303498B1 (sv)
TW (1) TW217383B (sv)
WO (1) WO1990002746A1 (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563475B1 (en) * 1992-03-25 2000-05-31 Immunogen Inc Cell binding agent conjugates of derivatives of CC-1065
US5502068A (en) * 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
EP1392359B2 (en) 2001-05-11 2013-03-13 Ludwig Institute for Cancer Research Ltd. Specific binding proteins and uses thereof
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
YU37904A (sh) 2001-11-09 2006-08-17 Boehringer Ingelheim Pharmaceuticals Inc. Benzimidazoli kao korisni inhibitori proteinske kinaze
AU2003257094A1 (en) * 2002-08-08 2004-02-25 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
JP2006505571A (ja) * 2002-10-15 2006-02-16 リゲル ファーマシューテイカルズ、インコーポレイテッド 置換されたインドール及びｈｃｖ阻害剤としてのその使用
CA2531485C (en) * 2003-07-07 2013-03-26 Merck Patent Gmbh Malonamide derivatives
US20050209284A1 (en) * 2004-02-12 2005-09-22 Boehringer Ingelheim Pharmaceuticals, Inc. Tec kinase inhibitors
JP2009504756A (ja) * 2005-08-17 2009-02-05 シェーリング コーポレイション 新規な高親和性のチオフェンベースおよびフランベースのキナーゼリガンド
CN104013956B (zh) 2007-01-25 2018-12-18 达娜-法勃肿瘤研究所公司 抗egfr抗体在治疗egfr突变体介导的疾病中的用途
WO2008115404A1 (en) 2007-03-15 2008-09-25 Ludwing Institute For Cancer Research Treatment method using egfr antibodies and src inhibitors and related formulations
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
ES2609915T3 (es) 2007-08-14 2017-04-25 Ludwig Institute For Cancer Research Ltd. Anticuerpo monoclonal 175 direccionado al receptor de EGF y derivados y usos del mismo
AU2009320481C1 (en) 2008-11-03 2016-12-08 Syntarga B.V. Novel CC-1065 analogs and their conjugates
LT2560645T (lt) 2010-04-21 2016-10-10 Syntarga B.V. Cc-1065 analogų ir bifunkcinių linkerių konjugatai
WO2014066400A2 (en) 2012-10-22 2014-05-01 Arnold Glazier Methods for the effective treatment of metastatic cancer
DE102013012622A1 (de) * 2013-07-30 2015-02-05 Clariant lnternational Ltd Neue sterisch gehinderte cyclische Amine
KR102323301B1 (ko) 2014-01-10 2021-11-09 비온디스 비.브이. Cys 연결된 항체-약물 접합체의 정제 방법
NZ722020A (en) * 2014-01-27 2018-05-25 Pfizer Bifunctional cytotoxic agents
AU2015282627B2 (en) 2014-06-30 2020-04-02 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
DE102015000124A1 (de) * 2015-01-07 2016-07-07 Clariant International Ltd. Verfahren zur Stabilisierung von Polyamiden
AU2016238551B2 (en) * 2015-03-20 2020-01-02 Pfizer Inc. Bifunctional cytotoxic agents containing the CTI pharmacophore

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169888A (en) * 1977-10-17 1979-10-02 The Upjohn Company Composition of matter and process
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
GB8528848D0 (en) * 1985-11-22 1985-12-24 Davy Mckee Poole Rolling mills
MX9203200A (es) * 1986-12-19 1992-09-01 Upjohn Co Analogos de cc. 1065 novedosos.

Also Published As

Publication number Publication date
LV12806A (en) 2002-03-20
AU632288B2 (en) 1992-12-24
US5541339A (en) 1996-07-30
NO910958L (no) 1991-05-10
AU4192289A (en) 1990-04-02
FI911193A0 (fi) 1991-03-11
FI103668B (sv) 1999-08-13
DK41791D0 (da) 1991-03-08
DK41791A (da) 1991-03-08
ATE198335T1 (de) 2001-01-15
DK175458B1 (da) 2004-11-01
LV12806B (lv) 2002-05-20
JP3380237B2 (ja) 2003-02-24
NO303498B1 (no) 1998-07-20
WO1990002746A1 (en) 1990-03-22
DE68929275D1 (de) 2001-02-01
NO910958D0 (no) 1991-03-11
KR0137959B1 (ko) 1998-05-15
TW217383B (sv) 1993-12-11
KR900701801A (ko) 1990-12-04
DE68929275T2 (de) 2001-05-23
GR3035589T3 (en) 2001-06-29
JPH04500664A (ja) 1992-02-06
CA1340215C (en) 1998-12-15

Similar Documents

Publication Publication Date Title
FI103668B1 (sv) Förfarande för framställning av farmakologiskt aktiva pyrrolo[3,2-e]indol-4(5H)-onidimerer
TR200000197T2 (tr) Yeni bileşimler
KR960009264B1 (en) Novel cc-1065 analogs
TR200000151T2 (tr) Yeni bileşimler.
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
ES2173876T3 (es) Nuevas 7-(sustituido)-8-(sustituido)-9-(amino sustituido)-6-desmetil-desoxitetraciclinas como agentes antibioticos.
EG18334A (en) Pyrozoline compounds and their use as pesticides
NO20000313L (no) Nye forbindelser
SE9702564D0 (sv) New compounds
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
NO985406D0 (no) Ikke-peptid G-CSF-etterligninger
SE9802574D0 (sv) Novel compounds
FI875501A (fi) 6,7-dihydro-/1,2,4/triazolo/1,5-a// 1,3,5/triazin-2-sulfonsyraamider, foerfarande foer deras framstaellning och deras anvaendning som medel med herbicid och vaextreglerande verkan.
BE898856A (fr) Analogues de mitomycine
DE3782831D1 (de) (gem-heterocyclodimethanamin-n,n')platin komplexe.
ATE41003T1 (de) Tetrazolothienopyridine.
BR8108862A (pt) Hidroximidato e tiol-hidroximidatos heterobiciclicos e seus derivados ester -carbamato com atividade biologica

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: PHARMACIA & UPJOHN COMPANY

MA Patent expired